Metformin inhibits the expression of the enzyme (CYP8B1) required for the synthesis of 12α-hydroxylated bile acid and inhibits the synthesis of cholic acid, which may be effective targets for the treatment of type 2 diabetes [13]. Here, CYP8B1 is linked to type 2 diabetes mellitus.